Navigation Links
FDA Approves Label Update for PREZISTA® to Include 192-Week Data in HIV-1-Infected Adult Patients Starting Treatment
Date:10/21/2011

ResultsThe ARTEMIS study compared the efficacy and safety of PREZISTA/r 800/100 mg once daily (n=343) versus lopinavir/r 800/200 mg total daily dose (n=346) in treatment-naive adults with HIV-1. All patients received a fixed-dose combination of tenofovir and emtricitabine once daily. At 192 weeks, PREZISTA/r was shown to be non-inferior to lopinavir/r. This 192 week analysis showed that:

-- 70% of patients in the PREZISTA/r arm reached an undetectable viral load (less than 50 copies/m.) vs. 61% of patients in the lopinavir/r arm.  Virologic failure was 12% in the PREZISTA/r arm and 15% in the lopinavir/r arm. Statistical superiority of PREZISTA/r over the lopinavir/r regimen was demonstrated in both the intent-to-treat (ITT) and on-protocol (OP) analysis.

-- The most common treatment-related adverse reactions (greater or equal to 5 percent) of moderate intensity (greater or equal to grade 2) among patients in the PREZISTA/r arm vs. lopinavir/r arm were: diarrhea (9 percent vs. 16 percent); headache (7 percent vs. 6 percent); abdominal pain (6 percent vs. 6 percent); and rash (6 percent vs. 7 percent).

About the ARTEMIS StudyARTEMIS (AntiRetroviral Therapy with TMC114 ExaMined In naive Subjects) is an international, randomized, controlled, open-label, non-inferiority, Phase 3 trial that compared the efficacy and safety of PREZISTA/r versus lopinavir/r in treatment-naive HIV-1-infected adult patients with viral load greater than 5,000 copies/mL.

The main objective of the study was to demonstrate non-inferiority of PREZISTA/r versus lopinavir/r in the proportion of patients achieving virologic response, defined as confirmed HIV RNA less than 50 copies/mL. Non-inferiority of PREZISTA/r vs. lopinavir/r was defined as a maximum allowable difference of 12 percent for virologic response, with a one-sided significance level of alpha equal to 0.025.

Important Safety Information PREZISTA does not cure HIV-1 infection or AIDS, and
'/>"/>

SOURCE Janssen Therapeutics, Division of Janssen Products, LP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body
2. FDA Approves Combination Therapy Juvisync
3. FDA Approves Cialis to Treat Benign Prostatic Hyperplasia
4. FDA Approves Remicade to Treat Ulcerative Colitis in Children Older Than 6 Years
5. FDA Approves Soliris for Rare Pediatric Blood Disorder
6. FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
7. FDA Approves Xalkori with Companion Diagnostic for a Type of Late-stage Lung Cancer
8. FDA Approves Firazyr To Treat Acute Attacks of Hereditary Angioedema
9. FDA Approves Adcetris to Treat Two Types of Lymphoma
10. FDA Approves the First Specific Treatment for Scorpion Stings
11. Cardinal Health Board of Directors Approves Cash Dividend, Elects David P. King as Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today ... will present at the Jefferies 2015 Global Healthcare Conference in ... on Monday, June 1, 2015. The conference ... listen only Webcast. To listen, please go to: http://ir.unilife.com/events.cfm ... for those unable to listen live. ...
(Date:5/28/2015)... MOUNTAIN VIEW, Calif. , May 28, 2015 ... healthcare informatics market, Frost & Sullivan recognizes ... Frost & Sullivan Award for Company of the ... effort to take HCM to the next level ... highly strategic acquisitions and followed them up with ...
(Date:5/28/2015)... 28, 2015  Freedom Meditech, Inc., a medical device ... from current blood-based standards to early and non-invasive detection, ... in a Series C financing. The company seeks to ... since founded. The company has also appointed Mr. ... member of the company,s board of directors. Mr. Gerace ...
Breaking Medicine Technology:Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 2Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 3Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 4Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 5Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 2Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 3Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 4
... LONDON and CRANBURY, N.J., Oct. 29 GlaxoSmithKline PLC ... today announced a definitive agreement to develop and commercialize ... for the treatment of Fabry disease, a rare inherited ... receive an exclusive worldwide license to develop, manufacture and ...
... Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will ... be held November 10-12, 2010 at the Arizona Biltmore Hotel ... scheduled to present an overview of the Company and its ... 2010. To listen to the audio web cast ...
Cached Medicine Technology:GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease 2GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease 3GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease 4GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease 5GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease 6Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference 2Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference 3
(Date:5/28/2015)... Spring House, PA (PRWEB) May 28, 2015 ... Bruce Dalglish, today announced a just launched blog series ... corporate cultures. Hosted on the “R. Bruce Dalglish” ... by decades of R. Bruce Dalglish’s corporate experience. ... impact that positive workplace cultures have upon the overall ...
(Date:5/28/2015)... TX (PRWEB) May 28, 2015 Ticket Down ... friendly soccer match between Mexico and Argentina in ... in the world will compete on the pitch at AT&T ... one another in an international friendly on Tuesday, September 8th ... most talented nations in the world including some of the ...
(Date:5/28/2015)... Edmond, OK (PRWEB) May 28, 2015 ... pain relief lotion and products, today announced their best-selling lotion ... bottle. Real Time Pain Relief is an FDA registered OTC ... natural and herbal ingredients, such as Aloe Vera, Arnica, Capsicum, ... a low level of Menthol – only 1.25% – to ...
(Date:5/28/2015)... Hexagon Geospatial is pleased to announce ... of engineering, spatial data and mapping services, is using ... point clouds for urban change assessments in Bernalillo County, ... BHI Spatial Data Division implemented a countywide approach to ... Collected by a variety of different digital aerial camera ...
(Date:5/28/2015)... Cancer survivors who participated in the LIVESTRONG ... fitness and quality of life, according to research conducted ... Jennifer Ligibel, MD, senior physician in the Susan F. ... The findings will be presented at this year’s ... in Chicago. , The study, designed to ...
Breaking Medicine News(10 mins):Health News:R. Bruce Dalglish, CEO of Alliance Hospice, Introduces New Blog Series On Positive Corporate Culture 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 3Health News:Real Time Pain Relief Introduces New Four Ounce Pump Bottle for their Popular Pain Relief Lotion 2Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 2Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 4
... DALLAS, April 6 As consumers continue to adopt ... their guests by adding new menu items to their ... of the first casual dining restaurant concepts to create ... to healthier items in 1993. Along with the addition ...
... Against a background of economic uncertainty, people across the ... terms of their wealth but also their health, according ... practice of DDB Worldwide Communications Group Inc.The study, recently ... Omnicom Group Inc., compares perceptions about health among more ...
... the First of Five New Markets Slated to Feature ... April 6 MoleSafe ( www.molesafe.com ), a company that ... has opened its second U.S. location in Albuquerque, New Mexico. ... Jersey, in 2008. MoleSafe originated in New Zealand, which is ...
... Information Workflow Drives Carefx,s Agenda at HIMSS Conference, ... 6 Carefx Corporation , ... existing systems and offers clinicians single, clinically relevant ... at this year,s Healthcare Information and Management Systems ...
... fund multiple sclerosis researchCHICAGO, April 6 The Illinois ... for MS education and awareness by purchasing the newest ... 4, 2009, the Lottery released "Dash! For Cash" to ... Cash" is the second instant game created to support ...
... Phase Focuses On Integration Of Health Information Exchange ComponentsCHICAGO, ... Harris Corporation (NYSE: HRS ) has been ... Network (NHIN) CONNECT contract by the Federal Health Architect ... Office of the National Coordinator. CONNECT is an ...
Cached Medicine News:Health News:Chili's Celebrates Women with Curves 2Health News:DDB Worldwide and M/A/R/C Research Find in Time of Economic Crisis: Health Is the New Wealth, Survey Shows Empowering Patients Is Key to Influence 2Health News:MoleSafe USA Opens Second Location in Albuquerque, New Mexico 2Health News:MoleSafe USA Opens Second Location in Albuquerque, New Mexico 3Health News:Carefx Showcases Expanded Fusionfx Solution Suite and Profiles Changing Roles of CIOs at Executive Roundtable 2Health News:Carefx Showcases Expanded Fusionfx Solution Suite and Profiles Changing Roles of CIOs at Executive Roundtable 3Health News:Carefx Showcases Expanded Fusionfx Solution Suite and Profiles Changing Roles of CIOs at Executive Roundtable 4Health News:Illinois Lottery Releases New MS Ticket, Dash! For Cash 2Health News:Illinois Lottery Releases New MS Ticket, Dash! For Cash 3Health News:Harris Corporation Awarded Follow-on Contract Option to Expand CONNECT Solution for Nationwide Health Information Network 2Health News:Harris Corporation Awarded Follow-on Contract Option to Expand CONNECT Solution for Nationwide Health Information Network 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: